NCT00482222 Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00480597 Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00480584 A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00479856 Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer Status TERMINATED Phase PHASE2
NCT00477464 Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00473005 Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast Status TERMINATED Phase PHASE1
NCT00470184 Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00469443 Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC Status COMPLETED Phase PHASE3
NCT00468585 Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model Status COMPLETED Phase PHASE1/PHASE2
NCT00454636 A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. Status COMPLETED Phase PHASE2
NCT00453323 Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT00452673 Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00450515 Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer Status WITHDRAWN Phase PHASE2
NCT00450203 Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT00448552 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00444678 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00440167 Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine Status UNKNOWN Phase PHASE3
NCT00438256 Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00438100 Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Status COMPLETED Phase PHASE2
NCT00437294 Enzastaurin in Combination of Capecitabine to Treat Breast Cancer Status TERMINATED Phase PHASE2